Arca
Skip to content

ABP-2000 G-3

System, Measurement, Blood-Pressure, Non-Invasive. 510(k) K021029, from Biotrac, Inc. (Miami, FL). Product code DXN, class 2.

As of Nov 17, 2026, K021029 is an FDA 510(k) held by Biotrac, Inc., substantially equivalent on Apr 12, 2002 after 14 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Apr 12, 2002
  • Review time: 14 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

It is intended to be used as an aid or support for the initial diagnosis and subsequent treatment's follow-up when it is necessary to measure a patient's blood pressure over a determined period of time. The system does not make any diagnose, it only measures, stores and displays the information.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other DXN Clearances

The newest 510(k)s for the same product code; their median review was 231 days; see every DXN device

Record

Type
Traditional, third-party review
Received
Mar 29, 2002
Review panel
Cardiovascular
Regulation
21 CFR 870.1130

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.